Background
Longitudinal whole-population studies can explore new dimensions in drug allergy research. Excipient allergy testing remains a barrier to allergy evaluation in countries without legislations mandating ingredient disclosure in registered drugs. The Comprehensive Excipient and Drug Allergy Registry (CEDAR) was established to investigate Hong Kong’s drug allergy landscape and potential role of excipient registries.